Research Cluster

Medication Trials for Autism Behaviors

This cluster looks at pills doctors tested to calm irritability, repetitive actions, and other hard behaviors in kids with autism. The studies show most medicines did not help much and could cause side effects. A few children with extra attention problems seemed to do a little better, but nothing worked like good ABA teaching. BCBAs can read this to know why drugs are not the first choice and why behavior plans stay the best tool.

75articles
1980–2026year range
5key findings
Key Findings

What 75 articles tell us

  1. Fluoxetine, bumetanide, minocycline, oxytocin, and intranasal ketamine have all failed to improve core autism symptoms over placebo in controlled trials.
  2. ADHD medications like atomoxetine modestly improve parent-rated attention symptoms in children with autism and ADHD, but gastrointestinal side effects are common.
  3. For children with autism who need MRI sedation, both propofol and dexmedetomidine are safe options, each with different tradeoffs in recovery time and vital stability.
  4. Dextromethorphan/quinidine showed a significant reduction in irritability scores versus placebo in autistic adults in one pilot trial.
  5. Most large-scale pharmacological trials for core autism behaviors have returned null or mixed results, reinforcing behavioral intervention as the primary treatment.
Free CEUs

Get 60+ CEUs Free in The ABA Clubhouse

Live CEU every Wednesday — ethics, supervision, and clinical topics. Always free.

Join Free →

Frequently Asked Questions

Common questions from BCBAs and RBTs

Most medications tested in rigorous trials have not shown benefit over placebo for core autism symptoms. Behavioral intervention has the strongest evidence for improving social communication and reducing repetitive behaviors.

Yes. Monitor for changes in engagement, compliance, or behavior. Document what you observe and share that information with the prescribing doctor. Medication effects — positive or negative — can change how a child responds during sessions.

Research shows ADHD medications like atomoxetine can modestly improve parent-rated attention symptoms in children with autism and ADHD. Expect possible side effects like gastrointestinal upset and sleep changes.

Be factual and calm. Controlled trials of intranasal oxytocin did not show significant benefit for autistic children's social processing. Encourage families to discuss experimental options with their medical team before trying them.

Yes. Research shows both propofol and dexmedetomidine are safe for sedation during procedures like MRI in autistic children. Propofol has faster recovery time; dexmedetomidine maintains more stable vital signs. The medical team will choose based on the specific procedure.